Brainstorm Cell Therapeutics reported $1.39M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US USD 2.85M 4.2M
Biogen BIIB:US USD 12.78B 903M
Brainstorm Cell Therapeutics BCLI:US USD 1.39M 6.46M
Cytokinetics CYTK:US USD -15977000 127.39M
Gilead Sciences GILD:US USD 21.21B 128M
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
Idera Pharmaceuticals IDRA:US USD 49.94M 28.81M